ALK-Abelló A/S (ALK-B.CO)
| Previous close | 97.55 |
| Open | 98.20 |
| Bid | 98.75 x 0 |
| Ask | 98.90 x 0 |
| Day's range | 97.85 - 99.20 |
| 52-week range | 91.75 - 162.10 |
| Volume | |
| Avg. volume | 342,349 |
| Market cap | 21.681B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 43.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 16 Mar 2017 |
| 1y target est | N/A |
- Globe Newswire
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions by managerial staff: The Board of Directors has previously granted share options and performance shares in ALK-Abelló A/S, re. company release no. 5/2020 of 19 March 2020. The right to share options and performance shares may be achieved in March 2023, provided that ALK achie
- Globe Newswire
Annual General Meeting in ALK on 23 March 2023
ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 23 March 2023 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached. ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel. +45 5054 1434 About ALKALK
- Globe Newswire
ALK appoints Claus Steensen Sølje as new Chief Financial Officer (CFO)
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Claus Steensen Sølje will take up the position as Executive Vice President, Chief Financial Officer (CFO) and member of the Board of Management no later than 1 June 2023. He succeeds Søren Jelert, whose decision to leave ALK was announced in November 2022. Claus Steensen Sølje, born 1972, a Danish citizen, will bring extensive experience to ALK from more than 20 years in various leadership roles at Novo Nordisk in Denmark, France and Switze
